Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2006
05/24/2006EP0872488B1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME
05/24/2006EP0804599B1 Mannose or xylose based positive selection
05/24/2006EP0746613B1 Recombinant humanized anti-fb5 antibodies
05/24/2006DE19946173B4 Expression der bovinen Acetyl-Coenzym A Carboxylase α Expression of bovine acetyl-coenzyme A carboxylase α
05/24/2006DE10208188B4 Behälter mit zumindest einer Elektrode Container having at least one electrode
05/24/2006CN2782696Y Cell funeral card
05/24/2006CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells
05/24/2006CN1777678A Method of treating ischemic disease
05/24/2006CN1777676A Schizophrenia-related voltage-gated ion channel gene and protein
05/24/2006CN1777437A Biologically active native biomatrix composition
05/24/2006CN1775947A Recombinant adenovirus capable of expressing tomour specific apoptosis peptide, and its preparing method and use
05/24/2006CN1775946A Enhanced virus-mediated DNA transfer
05/24/2006CN1775945A Method for in vitro inhibiting AF116909 gene induced nerve stem cells from directional differentiating into cholinergic neuron
05/24/2006CN1257284C Method of blocking expression of hepatitis B virus
05/24/2006CN1257283C Method and application for breeding transgenic plant with property of high antivirus
05/24/2006CN1257268C Preparation and application of cell-eliminating pig corium substrate without cytotoxicity
05/24/2006CN1257262C Pouring type biologic reactor system in vitro constructure of dual active skin
05/24/2006CN1257186C Interferon gamma polypeptide variants
05/24/2006CN1256987C Method for decellularising foreign material for production of bioprostheses
05/23/2006US7049499 Transgenic plant, seeds; herbicide resistance; insect resistance; disease resistance
05/23/2006US7049498 Inbred maize line 413A
05/23/2006US7049496 Soybean cultivar 2386009
05/23/2006US7049495 Soybean variety XB64C04
05/23/2006US7049494 Hybrid soybean seeds;gn
05/23/2006US7049491 Expression vector comprising DNA sequences coding modified insecticidal protein (CRY1AB) for biological pest control
05/23/2006US7049490 Comprises DNA encoding enzymatic polypeptide associated with dwarfed plant phenotypes and gibberellin biosynthesis; plant growth regulators
05/23/2006US7049489 Transgenic plant; transformation plant with nucleic acids; gene expression; shutter vectors; genetic engineering
05/23/2006US7049487 Transgenic plants carrying neoxanthin cleavage enzyme gene
05/23/2006US7049484 Commercial production of proteases in plants
05/23/2006US7049480 Methods of enucleating an avian oocyte or zygote using two-photon laser scanning microscopy
05/23/2006US7049427 From plants having decreased content of anthocyanins; enzyme inhibitors
05/23/2006US7049426 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/23/2006US7049422 Tumor necrosis related receptor, TR7
05/23/2006US7049413 MAGE-A3 peptides presented by HLA class II molecules
05/23/2006US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies
05/23/2006US7049411 Human anti-factor IX/IXa antibodies
05/23/2006US7049408 Preferential polypeptide; for use in the diagnosis and treatment of arthritis
05/23/2006US7049406 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin
05/23/2006US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof
05/23/2006US7049402 Tumor necrosis factor receptor-5
05/23/2006US7049286 Insulin conjugates and methods of use thereof
05/23/2006US7049145 Vaccinia virus MVA-E3L-knockout-mutants and use thereof
05/23/2006US7049143 Derived from the murine leukemia virus, comprises elongation factor-alpha; for gene therapy
05/23/2006US7049141 Use of collagenase in the preparation of neural stem cell cultures
05/23/2006US7049140 X-ray guided drug delivery
05/23/2006US7049139 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
05/23/2006US7049138 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/23/2006US7049137 KCNQ5, a novel potassium channel
05/23/2006US7049136 Redirection of cellular immunity by receptor chimeras
05/23/2006US7049127 Method of producing infectious reovirus
05/23/2006US7049125 EGVIII endoglucanase and nucleic acids encoding the same
05/23/2006US7049124 Hyaluronidase from the Hirudinaria manillensis isolation, purification and recombinant method of production
05/23/2006US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/23/2006US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes
05/23/2006US7049113 to the luciferin-luciferase reaction system; culturing a host cell, isolation of the protein; genetic engineering; improved durability of luminescence
05/23/2006US7049111 hydroxymethylglutaryl coenzyme A reductase; isolated DNA; recombinant DNA vector; transformed cell; culturing the transformed cell to produce a hydroxylase; hydroxylation, separation; anticholesterol agents
05/23/2006US7049099 Recombinant human mannan-binding proteins and producing method of the same
05/23/2006US7049097 Antibiotics-independent vector for constant high-expression and method for gene expression using the same
05/23/2006US7049094 Detection of modulator of transport protein activity; obtain sample containing transport protein, incubate with potential modulator, monitor binding activity, reduction in binding indicates effective modulator
05/23/2006US7049084 Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore
05/23/2006US7049083 Methods for identifying modulators of N-type ion channel inactivation
05/23/2006US7049075 Deoxyribonuclease IIβ proteins and cDNAs
05/23/2006US7049072 Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
05/23/2006US7049071 Nucletide sequences coding protein for use as diagnostic tool in the detection of genetic damage
05/23/2006US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV)
05/23/2006US7049057 Tissue engineered uterus
05/23/2006US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports
05/23/2006US7048934 Combined regulation of neural cell production
05/23/2006US7048922 Protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of
05/23/2006US7048921 Neural transplantation using pluripotent neuroepithelial cells
05/23/2006US7048915 Composition for cell-free protein synthesis
05/23/2006US7048856 Filtering blood; medical diagnosis; bioreactor; porous membrane
05/23/2006CA2547572A1 Cattle beta-casein gene targeting vector using homologous recombination
05/23/2006CA2245514C Fractionation using dielectrophoresis and field flow fractionation
05/18/2006WO2006053246A2 A new sos 1 gene from halophila that confers salt tolerance
05/18/2006WO2006053021A2 Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby
05/18/2006WO2006052991A2 Parathyroid hormone receptor activation and stem and progenitor cell expansion
05/18/2006WO2006052960A2 METHODS AND COMPOSITIONS FOR INCREASING STEM CELL HOMING USING Gαs ACTIVATORS
05/18/2006WO2006052925A2 Cardiac stem cells
05/18/2006WO2006052836A2 A system and method for establishing a local page and grid numbering system in a georgraphic referencing system
05/18/2006WO2006052646A2 Derivation of embryonic stem cells
05/18/2006WO2006052551A2 Micromachined bilayer unit of engineered tissues
05/18/2006WO2006052534A2 Expansion of nk cells and therapeutic uses thereof
05/18/2006WO2006052223A1 Cell culture device
05/18/2006WO2006051944A1 Fluorescent protein
05/18/2006WO2006051538A2 Cells isolated from placenta, device for isolating same, and uses thereof
05/18/2006WO2006051515A1 A device comprising a sample of reconstructed tissue and a detection system
05/18/2006WO2006051418A2 Transcription factor of the zn binuclear cluster family of fungal regulators
05/18/2006WO2006051405A2 Methods and means related to cancer stem cells
05/18/2006WO2006051112A1 Stem cells, method for their purification, identification, and use
05/18/2006WO2006050949A2 Superagonistic anti-cd28 antibody
05/18/2006WO2006050667A1 MONOCLONAL ANTIBODIES AGAINST APOPTOSIS-RELATED ACETYLCHOLINESTERASE (AR-AChE) AND USE THEREOF
05/18/2006WO2006031273A3 Cellular phenotype
05/18/2006WO2006029198A3 Culturing human embryonic stem cells
05/18/2006WO2005117577A3 Model for neurodegenerative disorders
05/18/2006WO2005085424A3 Endothelial progenitor cells and methods of use thereof
05/18/2006WO2005067491A3 Toxin complex proteins and genes from xenorhabdus bovienii
05/18/2006WO2005035726A3 Multi-layered polymerizing hydrogels for tissue regeneration
05/18/2006WO2004104183A3 Method for the in vitro production of cartilage-like tissue
05/18/2006WO2004074457A3 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions